The dengue virus envelope glycoprotein mediates virus attachment and entry and is the major viral antigen. The identification of 'critical' amino acids in the envelope glycoprotein that cannot be altered without loss of infectivity could have a major impact on the development of dengue virus vaccines and diagnostics. In this context, we determined whether six amino acids, previously predicted by computational analysis to play a critical role in the virus life cycle, were essential for virus viability. The effects of mutating the six 'critical' amino acids and a further seven 'neutral' amino acids were analysed by using a dengue virus type 2 infectious cDNA clone. Of the six critical amino acids, three (Asp-215, Pro-217 and His-244) were found to be essential for virus viability in mammalian and mosquito cells.
The four serotypes of dengue virus (DENV types 1-4) are mosquito-borne flaviviruses that infect up to 50 million individuals annually in subtropical and tropical regions of the world (Gubler, 2002; Kyle & Harris, 2008) . Dengue is the most important arthropod-borne viral disease of humans and is described as an emerging disease because of its dramatic resurgence in recent years (Mackenzie et al., 2004) . The DENV particle consists of three structural proteins: the two membrane-anchored surface proteins, premembrane/membrane (prM/M) and envelope (E), and the capsid (C) protein that surrounds the RNA genome to form the nucleocapsid (Lindenbach et al., 2007) . The E protein is of particular importance to virus virulence, as it is required for receptor binding and fusion during entry of the virus particle and is the major antigenic determinant, inducing antibodies protective against DENV infection (Churdboonchart et al., 1991; Crill & Roehrig, 2001 ; Roehrig, 1997; Stiasny & Heinz, 2006) . Cryo-electron microscopy studies of DENV particles have shown that, during the virus life cycle, the E protein undergoes a number of structural rearrangements in the virus particle involving the formation of E protein dimers and trimers (Kuhn et al., 2002; Mukhopadhyay et al., 2005; Zhang et al., 2003 Zhang et al., , 2004 . The X-ray structure of a flavivirus E protein was first determined for the soluble dimeric ectodomain of the tick-borne encephalitis virus (TBEV) E protein (Rey et al., 1995) . Subsequently, the structures of the DENV-2 (Modis et al., 2003; Zhang et al., 2004) and DENV-3 (Modis et al., 2005 ) E protein ectodomains have been determined, both as dimers and as post-fusion trimers (Modis et al., 2004) .
A study by Mazumder et al. (2007) used computational analysis to identify six amino acid residues (Asn-37, Gln-211, in the DENV E protein sequence that are conserved, lie in predicted consensus T-cell epitopes and are exposed on the surface of the E protein when in either a dimeric or a trimeric conformation. It was hypothesized that these residues were 'critical' for virus replication. The ability to identify 'critical' amino acids, which cannot be altered without loss of infectivity, by computational analysis would be of great importance to the development of DENV vaccines and diagnostics. In this study, we used a reverse-genetic approach to examine the validity of the bioinformatic predictions. Mutations encoding substitutions at the six previously proposed 'critical' amino acids and six other amino acids that were predicted to play a 'neutral' role in the virus life cycle were introduced into a DENV-2 infectious cDNA clone and the effects of the mutations on virus viability were examined. The six neutral amino acids were not (i) under negative selection, (ii) exposed or interface residues in either the dimer or trimer, (iii) part of the top five ranking T-cell epitopes, (iv) strictly conserved in flaviviruses, (v) transmembrane or (vi) located in regions involved in receptor binding. In addition, an amino acid change at residue 390 (N390D), which affected virus replication in primary monocyte-derived macrophages but not in Aedes albopictus C6/36 cells , was included as a control to account for any systematic bias that could result from the methodology that we used to produce mutations or evaluate virus recovery.
Mutations encoding changes to E protein amino acids (Table 1) were introduced into a DENV-2 strain New Guinea C infectious cDNA clone (which yields virus v601) by overlap PCR using specifically designed mutagenic primers as described previously (Gualano et al., 1998; Pryor et al., 2001) . RNA was transcribed from the parental and each of the 13 mutant constructs in vitro and transfected into BHK-21 cells and C6/36 cells as described previously (Kroschewski et al., 2008) . The quality and quantity of the RNA transcripts were verified by agarose gel electrophoresis and A 260 reading, to ensure that equal amounts of each RNA transcript were used for transfection. After 3 days, the cells were examined for evidence of E protein expression by indirect immunofluorescence assay (IFA) using a mixture of anti-E protein monoclonal antibodies (Gualano et al., 1998) , and the cell-culture media were collected and passaged twice in C6/36 cells to amplify virus stocks that were titrated by TCID 50 assay on Vero cells (Kroschewski et al., 2008) . RNA was extracted from the C6/36 or BHK-21 cell-culture supernatants both at various times post-transfection and after the two subsequent passages in C6/36 cells, and used for RT-PCR as described previously (Gualano et al., 1998; Kroschewski et al., 2008) . cDNA corresponding to the prM and E genes was sequenced to confirm the retention of introduced mutations in the virus genome. Quantitative RT-PCR (qRT-PCR) was used to measure the amounts of mutant and wild-type DENV RNA in the culture supernatants of BHK-21 cells after transfection. qRT-PCR was performed by using an iScript One-Step RT-PCR kit with SYBR Green and the CFX96 Real-Time PCR Detection system (both from Bio-Rad), using the primer set (d2C16A and d2C46B) described by Wang et al. (2002) .
Analysis by IFA of E protein expression in either BHK-21 or C6/36 cells initially transfected with the wild-type or mutant transcripts showed that none of the mutations abolished the production of the E protein completely, but that there were differences in the numbers of cells producing E protein (Table 1 ; Fig. 1a ). Previous studies (Kroschewski et al., 2008; Matusan et al., 2001 ) and the inclusion of a replication-defective mutant in the analysis (Fig. 1a) showed that E protein production at 3 days post-transfection could only be observed if genome replication had occurred. The IFA analysis suggested that, whilst all of the RNA transcripts were replicationcompetent, the mutations D215A, P217A and H244A debilitated either the release or the spread of infectious virus from the initially transfected cells (Fig. 1a) . The results of the IFA analysis were supported by qRT-PCR analysis of virus RNA isolated from the culture supernatants of BHK-21 cells transfected with in vitro transcripts (i) containing the six critical mutations, (ii) containing a lethal mutation in the NS5 gene or (iii) corresponding to v601. The mutations D215A, P217A and H244A prevented a sustained increase in extracellular virus RNA production over the period 24-72 h posttransfection. However, compared with transcripts containing a lethal mutation, there was an initial production of extracellular virus RNA, suggesting that virus particles were produced and released from these cells, but were non-infectious. The mutations N37A, Q211A and K246A did not appear to impair the production of infectious virus from initially transfected cells significantly.
The second-passage C6/36 cell-culture supernatants derived from the culture supernatants of cells initially transfected with in vitro transcripts containing the critical and neutral mutations were analysed for the presence of virus by RT-PCR/sequencing and TCID 50 assay (Table 1) . Detectable amounts of virus were not recovered from cells transfected with RNA transcripts containing the D215A, P217A or H244A mutations despite repeated attempts, confirming that these mutations abolished the production of infectious virus. All of the other mutations previously considered critical, as well as the neutral mutations, had little effect on virus recovery, with the exception of the neutral mutation A369V, which led to a 100-fold decrease in virus titre (Table 1) . Sequencing of the RT-PCR products confirmed the presence of each of the introduced mutations in the virus genome.
The growth of each mutant virus was analysed on C6/36 and Vero cells over a 4 day infection period to determine the effects of each mutation on virus replication. Of the six mutations originally considered 'critical', only three led to the recovery of infectious virus (N37A, Q211A and K246A). Analysis of the growth curves in C6/36 cells showed that viruses containing the mutations N37A and K246A replicated comparably to the wild-type virus (v601) over the infection period (Fig. 2a) . In comparison, growth of the virus containing the Q211A mutation was delayed and reached an overall lower titre than v601. Analysis of the growth properties of the viruses in Vero cells (Fig. 2c) showed similar replication patterns for viruses containing the K246A and Q211A mutations, whilst the N37A mutation reduced virus growth relative to v601.
Growth-curve analysis of viruses containing the 'neutral' mutations (S7A, Q148A, V251A, T359A, K361A, A369V and N390D) in C6/36 cells (Fig. 2b) showed that they replicated similarly to v601, with the exception of the virus containing the V251A mutation, which reduced virus replication. Analysis of the growth of viruses containing the 'neutral' mutations in Vero cells (Fig. 2d) showed a wider range of growth kinetics compared with C6/36 cells. In both cell types, viruses containing the mutations S7A and K361A replicated similarly to v601, whilst virus containing the V251A mutation reduced virus replication. In contrast, the growth of viruses containing the mutations Q148A, T359A and N390D showed an approximately 10-fold reduction compared with v601, whilst the growth of virus containing the A369V mutation was much more impaired in Vero cells (Fig. 2d ) than in C6/36 cells, with a 20-fold reduction in maximal titre compared with v601.
Of the six residues predicted to be critical for virus viability, three (Asp-215, Pro-217 and His-244) could not at each time point were determined by comparison to a standard curve produced by using standard amounts of the v601 RNA transcript and analysed by using the CFX Manager software package (Bio-Rad). Each assay was performed in triplicate; error bars indicate SD. &, v601; m, N37A; ., Q211A; h, D215A; h, P217A; g, H224A; X, K246A; #, Rep ("").
tolerate substitution to Ala and are therefore essential to virus replication, as predicted by computational analysis. As RNA transcripts containing these mutations replicated in initially transfected cells (Fig. 1) , but did not result in the production of infectious virus (Table 1 ; Fig. 1 ), any of these three mutations must impair virus assembly, release or entry. Interestingly, Asp-215 and His-244 are the only residues, of those selected for mutagenesis, that are strictly conserved in all flaviviruses. Structural analysis shows that they are likely to be involved in maintaining the conformation of the E protein at various stages in the virus life cycle. Analysis of the TBEV and DENV-2 E proteins in the trimeric post-fusion conformation showed that Asp-215 is involved in stabilization of the trimer (Bressanelli et al., 2004; Modis et al., 2004) . The recent determination of the X-ray structure of the DENV-2 prM protein linked to the E protein shows that His-244 is situated in the prM-E interface and interacts with Asp-63 in the pr protein . His-244 was postulated to be an important sensor of pH, reducing the interaction of the E protein with pr as the pH is raised to neutral during flavivirus release, leading to the dissociation of pr from the mature extracellular virus particle Yu et al., 2008) . In addition, examination of the role, in fusion, of conserved His residues in the TBEV E protein revealed that, although His-248 (His-244 in DENV-2) was not required for initiating fusion, mutation of His-248 and His-287 in combination (His-244 and His-283 in DENV-2) reduced post-fusion E protein trimer formation and stability (Fritz et al., 2008) .
The remaining mutations that were previously considered 'critical' (N37A, Q211A and K246A) could be recovered in infectious virus. These mutations were stably maintained in the virus genome after two passages in C6/36 cells, indicating that there was not strong selective pressure for reversion in these cells. Analysis of the growth of the mutant viruses showed that the mutation K246A had no effect on virus replication. Analysis of Lys-246 in the prM-E X-ray structure showed that, whilst it was located in close proximity to His-244 in the pr protein contact area, it did not interact directly with pr . Although the mutations N37A and Q221A had a moderate effect on virus replication in C6/36 and Vero cells or in Vero cells alone, respectively, the effect of these two mutations was no more intense than that observed for some of the 'neutral' mutations. With one exception, mutation of the seven neutral residues did not affect replication in C6/36 cells. Val-251 was the most conserved residue of the neutral mutations and mutating this residue to Ala was found to reduce virus replication moderately (approx. 100-fold) in C6/36 and Vero cells. Compared with their replication in C6/36 cells, the replication patterns of viruses containing the 'neutral' mutations were more diverse in Vero cells, an effect observed in other studies comparing the replication of flaviviruses with E protein mutations in mammalian and mosquito cells (Hanna et al., 2005; Mondotte et al., 2007) .
Computational analysis identified six of the 495 residues in the DENV-2 E protein as being 'critical' for virus replication (Mazumder et al., 2007) and, of these, we have shown three to be essential for virus replication when mutated in the context of the virus genome. Thus, although current bioinformatic tools have limitations in identifying residues that can tolerate alteration, computational analysis should save considerable effort by screening long sequences for potential critical sites to be validated by subsequent reverse genetics, as reported here. As the effects of the 'critical' mutations were only tested under cellculture conditions in vitro, the possibility remains that the 'critical' residues that did not abolish virus replication could play an important role in virus spread and pathogenesis in vivo, as suggested by mutation of DENV- 
